WestPark Capital Announces Completion of $5.8 Million Registered Direct Offering Priced At-The-Market for Lixte Biotechnology Holdings, Inc. (Nasdaq: LIXT)

WPCapital
(310) 843-9300
Follow Us:  Follow WestPark Capital on Facebook  Follow WestPark Capital on Twitter  Follow WestPark Capital on LinkedIn  Follow WestPark Capital on YouTube 

Press Releases